Fingolimod Hydrochloride

interferon alpha 1 ; Homo sapiens

3 Article(s)
Pub. Year
#Total Relationships
1 29854416 Relapse Rate and MRI Activity in Young Adult Patients With Multiple Sclerosis: A Post Hoc Analysis of Phase 3 Fingolimod Trials. 2018 Apr-Jun 1
2 26111826 Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study. 2016 May 2
3 24059944 Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis. 2013 Dec 1